For adults with rheumatoid arthritis (RA) or giant cell arthritis (GCA), Actemra may seem like the answer to chronic discomfort, but these people soon realize that the drug does more harm than good.
At least 1,128 Actemra-related deaths have been reported to the FDA since its approval in 2010.
DANGEROUS SIDE EFFECTS NOT ON THE LABEL
Patients treated with Actemra have an increased risk of:
- Heart Attack
- Heart Failure
- Lung Disease
Researchers say Actemra may cause these side effects at higher rates than similar drugs, like Humira, that do have proper warnings. One study even found the rate of stroke and heart failure were 1.5 times higher in Actemra patients compared to patients on a different medication.
APPROVE FIRST, MONITOR LATER
In short-term studies, Actemra seemed safe for patients to use. Then again, a similar drug called Vioxx seemed safe, too. Vioxx had to be pulled from the market in 2004 because it increased patients’ risk of heart attack and stroke.
When questioned, the FDA declines to comment about Actemra side effects. A spokeswoman writes that the organization “continually monitors post-marketing safety of approved drug products and remains committed to informing the public” about safety issues as they arise.
If you or a loved one has suffered serious side effects from Actemra, you may have a potential claim. Contact your team of dedicated harmful drug lawyers at Pintas & Mullins Law Firm to get started with your free consultation today. You pay us nothing unless we win you a settlement.